---
title: "CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD (CYCCP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CYCCP.US.md"
symbol: "CYCCP.US"
name: "CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD"
industry: "Oncology Biopharmaceuticals"
---

# CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD (CYCCP.US)

| Item | Detail |
|------|--------|
| Industry | Oncology Biopharmaceuticals |

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:14.000Z

**Overall: D (0.79)**

**Industry**: Oncology Biopharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 2 |
| Industry Median | D |
| Industry Average | D |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | 0.00% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 449000.00 |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -810.40% | E |
| Profit Margin | -18150.00% | E |
| Gross Margin | 100.00% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% | C |
| Net Profit YoY | 0.00% | C |
| Total Assets YoY | -56.94% | E |
| Net Assets YoY | -122.57% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -2.26% | D |
| OCF YoY | 0.00% | C |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.01 | E |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 118.03% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-810.40%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-18150.00%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "100.00%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "0.00%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-56.94%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-122.57%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-2.26%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "0.00%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.01",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "118.03%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | BIO GREEN MED SOLUTION INC. 6% CNV PFD USD (US.BGMSP) | E | C | E | A | C | D |
| 02 | CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD (US.CYCCP) | D | D | E | E | D | D |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CYCCP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CYCCP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CYCCP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
